ALKERMES INC 4
4 · ALKERMES INC · Filed Sep 20, 2011
Insider Transaction Report
Form 4
ALKERMES INCALKS
SKALETSKY MARK B
Director
Transactions
- Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−20,000→ 0 totalExercise: $14.92Exp: 2020-10-05→ Common Stock (20,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−15,000→ 0 totalExercise: $11.84Exp: 2014-09-23→ Common Stock (15,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−20,000→ 0 totalExercise: $11.44Exp: 2018-10-07→ Common Stock (20,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−20,000→ 0 totalExercise: $14.04Exp: 2016-09-21→ Common Stock (20,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−20,000→ 0 totalExercise: $18.29Exp: 2017-10-09→ Common Stock (20,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−20,000→ 0 totalExercise: $8.98Exp: 2019-10-06→ Common Stock (20,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−20,000→ 0 totalExercise: $16.77Exp: 2015-09-23→ Common Stock (20,000 underlying) - Disposition to Issuer
Common Stock
2011-09-16−5,000→ 0 total - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2011-09-16−24,000→ 0 totalExercise: $14.49Exp: 2014-06-01→ Common Stock (24,000 underlying)
Footnotes (3)
- [F1]Disposition made in connection with the conversion of shares pursuant to the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger") into an equal number of ordinary shares of Alkermes plc having a market value, based on the closing price on the effective date of the Merger, of $16.57 per share.
- [F2]These options are fully vested in accordance with their terms.
- [F3]Options assumed/converted in the Merger into the right to buy the same number of ordinary shares of Alkermes plc on substantially the same terms.